Search research articles
Contact Us
Filters
Showing results (131-140 of 177) with videos related to
Page
of 18
Sort By:
Oncology Research and Treatment
|
January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in Germany
Olaf Penack, Peter Dreger, Salem Ajib, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 25, 2017
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation
Daniela Weber, Robert R Jenq, Jonathan U Peled, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Frontiers in Immunology
|
November 7, 2022
Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation
Carina Matos, Andreas Mamilos, Pranali N Shah, et al.
Transplantation and Cellular Therapy
|
March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host Disease
Daniel Wolff, Carlos Solano, David Michonneau, et al.
Frontiers in Transplantation
|
July 12, 2024
Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease-an analysis from transplant centers across Europe
Ronja Langer, Antonela Lelas, Michael Rittenschober, et al.
Cornea
|
December 14, 2011
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD
Tina Dietrich-Ntoukas, Claus Cursiefen, Henrike Westekemper, et al.
Haematologica
|
June 16, 2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial
Helene M Schoemans, Kathy Goris, Raf Van Durm, et al.
Annals of Hematology
|
June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation
Stefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2015
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report
Stephanie J Lee, Daniel Wolff, Carrie Kitko, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 177) with videos related to
Sort By:
Page
of 18
Oncology Research and Treatment
|
January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in Germany
Olaf Penack, Peter Dreger, Salem Ajib, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 25, 2017
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation
Daniela Weber, Robert R Jenq, Jonathan U Peled, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Frontiers in Immunology
|
November 7, 2022
Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation
Carina Matos, Andreas Mamilos, Pranali N Shah, et al.
Transplantation and Cellular Therapy
|
March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host Disease
Daniel Wolff, Carlos Solano, David Michonneau, et al.
Frontiers in Transplantation
|
July 12, 2024
Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease-an analysis from transplant centers across Europe
Ronja Langer, Antonela Lelas, Michael Rittenschober, et al.
Cornea
|
December 14, 2011
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD
Tina Dietrich-Ntoukas, Claus Cursiefen, Henrike Westekemper, et al.
Haematologica
|
June 16, 2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial
Helene M Schoemans, Kathy Goris, Raf Van Durm, et al.
Annals of Hematology
|
June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation
Stefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2015
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report
Stephanie J Lee, Daniel Wolff, Carrie Kitko, et al.
Page
of 18